Labeler
Oryza Pharmaceuticals Inc. NDC Codes
Oryza Pharmaceuticals Inc. lists 22 finished drug products in the FDA NDC Directory under NDC labeler code 72516.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Metoprolol succinate, Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate, Carbamazepine ER, Ticagrelor, buPropion Hydrochloride XL, Oseltamivir Phosphate for Oral Suspension, Papaverine Hydrochloride
- Active ingredients
- Dextroamphetamine saccharate, Amphetamine aspartate monohydrate, Dextroamphetamine sulfate, Amphetamine sulfate, Metoprolol succinate, Metoprolol tartrate, Carbamazepine, Ticagrelor, Bupropion hydrochloride, Oseltamivir phosphate, Papaverine hydrochloride
- NDC labeler codes
- 72516
- Strengths
- Carbamazepine 200 mg/1; Carbamazepine 400 mg/1; Metoprolol succinate 25 mg/1; Ticagrelor 60 mg/1; Oseltamivir phosphate 6 mg/mL; Metoprolol succinate 50 mg/1; Metoprolol succinate 100 mg/1; Metoprolol succinate 200 mg/1; Ticagrelor 90 mg/1; Metoprolol tartrate 25 mg/1; Metoprolol tartrate 50 mg/1; Metoprolol tartrate 100 mg/1; Metoprolol tartrate 200 mg/1; Papaverine hydrochloride 30 mg/mL; Dextroamphetamine saccharate 7.5 mg/1; Amphetamine aspartate monohydrate 7.5 mg/1; Dextroamphetamine sulfate 7.5 mg/1; Amphetamine sulfate 7.5 mg/1; Dextroamphetamine saccharate 5 mg/1; Amphetamine aspartate monohydrate 5 mg/1
- Dosage forms
- Tablet, Extended release, Tablet, Powder, For suspension, Injection, Solution
- Routes
- Oral, Intravenous
- Drug classes (FDA established)
- Central Nervous System Stimulant, beta-Adrenergic Blocker, Mood Stabilizer, P2Y12 Platelet Inhibitor, Aminoketone, Neuraminidase Inhibitor
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 39
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Carbamazepine ERcarbamazepine | Carbamazepine 200 mg/1 | Tablet, Extended releaseOral | 72516-020 | 72516-0020-01 | — |
| Carbamazepine ERcarbamazepine | Carbamazepine 400 mg/1 | Tablet, Extended releaseOral | 72516-021 | 72516-0021-01 | — |
| Metoprolol succinate | Metoprolol succinate 25 mg/1 | Tablet, Extended releaseOral | 72516-025 | 72516-0025-0172516-0025-1072516-0025-50 | — |
| Ticagrelor | Ticagrelor 60 mg/1 | TabletOral | 72516-017 | 72516-0017-06 | — |
| Oseltamivir Phosphate for Oral Suspensionoseltamivir phosphate | Oseltamivir phosphate 6 mg/mL | Powder, For suspensionOral | 72516-029 | 72516-0029-01 | — |
| Metoprolol succinate | Metoprolol succinate 50 mg/1 | Tablet, Extended releaseOral | 72516-026 | 72516-0026-0172516-0026-1072516-0026-50 | — |
| Metoprolol succinate | Metoprolol succinate 100 mg/1 | Tablet, Extended releaseOral | 72516-027 | 72516-0027-0172516-0027-1072516-0027-50 | — |
| Metoprolol succinate | Metoprolol succinate 200 mg/1 | Tablet, Extended releaseOral | 72516-028 | 72516-0028-01 | — |
| Ticagrelor | Ticagrelor 90 mg/1 | TabletOral | 72516-018 | 72516-0018-06 | — |
| Metoprolol Succinate | Metoprolol tartrate 25 mg/1 | Tablet, Extended releaseOral | 72516-030 | 72516-0030-0172516-0030-1072516-0030-50 | — |
| Metoprolol Succinate | Metoprolol tartrate 50 mg/1 | Tablet, Extended releaseOral | 72516-031 | 72516-0031-0172516-0031-1072516-0031-50 | — |
| Metoprolol Succinate | Metoprolol tartrate 100 mg/1 | Tablet, Extended releaseOral | 72516-032 | 72516-0032-0172516-0032-1072516-0032-50 | — |
| Metoprolol Succinate | Metoprolol tartrate 200 mg/1 | Tablet, Extended releaseOral | 72516-033 | 72516-0033-01 | — |
| Papaverine Hydrochloride | Papaverine hydrochloride 30 mg/mL | Injection, SolutionIntravenous | 72516-024 | 72516-0024-1072516-0024-25 | — |
| Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate | Dextroamphetamine saccharate 7.5 mg/1 + 3 more ingredients | TabletOral | 72516-011 | 72516-0011-01 | — |
| Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate | Dextroamphetamine saccharate 5 mg/1 + 3 more ingredients | TabletOral | 72516-012 | 72516-0012-01 | — |
| Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate | Dextroamphetamine saccharate 3.75 mg/1 + 3 more ingredients | TabletOral | 72516-013 | 72516-0013-01 | — |
| Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate | Dextroamphetamine saccharate 2.5 mg/1 + 3 more ingredients | TabletOral | 72516-014 | 72516-0014-01 | — |
| Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate | Dextroamphetamine saccharate 1.875 mg/1 + 3 more ingredients | TabletOral | 72516-015 | 72516-0015-01 | — |
| Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate | Dextroamphetamine saccharate 1.25 mg/1 + 3 more ingredients | TabletOral | 72516-016 | 72516-0016-01 | — |
| buPropion Hydrochloride XLbupropion hydrochloride | Bupropion hydrochloride 150 mg/1 | Tablet, Extended releaseOral | 72516-035 | 72516-0035-0372516-0035-0972516-0035-50 | — |
| buPropion Hydrochloride XLbupropion hydrochloride | Bupropion hydrochloride 300 mg/1 | Tablet, Extended releaseOral | 72516-036 | 72516-0036-0372516-0036-0972516-0036-50 | — |
Oryza Pharmaceuticals Inc.: common questions
- What is Oryza Pharmaceuticals Inc.'s NDC labeler code?
- 72516. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Oryza Pharmaceuticals Inc.?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.